232 related articles for article (PubMed ID: 22489278)
1. Integrated intravital microscopy and mathematical modeling to optimize nanotherapeutics delivery to tumors.
van de Ven AL; Wu M; Lowengrub J; McDougall SR; Chaplain MA; Cristini V; Ferrari M; Frieboes HB
AIP Adv; 2012 Mar; 2(1):11208. PubMed ID: 22489278
[TBL] [Abstract][Full Text] [Related]
2. Modeling of nanotherapeutics delivery based on tumor perfusion.
van de Ven AL; Abdollahi B; Martinez CJ; Burey LA; Landis MD; Chang JC; Ferrari M; Frieboes HB
New J Phys; 2013 May; 15():55004. PubMed ID: 24039540
[TBL] [Abstract][Full Text] [Related]
3. Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution.
van de Ven AL; Kim P; Haley O; Fakhoury JR; Adriani G; Schmulen J; Moloney P; Hussain F; Ferrari M; Liu X; Yun SH; Decuzzi P
J Control Release; 2012 Feb; 158(1):148-55. PubMed ID: 22062689
[TBL] [Abstract][Full Text] [Related]
4. Current advances in mathematical modeling of anti-cancer drug penetration into tumor tissues.
Kim M; Gillies RJ; Rejniak KA
Front Oncol; 2013 Nov; 3():278. PubMed ID: 24303366
[TBL] [Abstract][Full Text] [Related]
5. Image-based spatio-temporal model of drug delivery in a heterogeneous vasculature of a solid tumor - Computational approach.
Moradi Kashkooli F; Soltani M; Rezaeian M; Taatizadeh E; Hamedi MH
Microvasc Res; 2019 May; 123():111-124. PubMed ID: 30711547
[TBL] [Abstract][Full Text] [Related]
6. Transient mild hyperthermia induces E-selectin mediated localization of mesoporous silicon vectors in solid tumors.
Kirui DK; Mai J; Palange AL; Qin G; van de Ven AL; Liu X; Shen H; Ferrari M
PLoS One; 2014; 9(2):e86489. PubMed ID: 24558362
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of Nanomedicine in Tumor Spheroid as an
Roy SM; Garg V; Barman S; Ghosh C; Maity AR; Ghosh SK
Front Bioeng Biotechnol; 2021; 9():785937. PubMed ID: 34926430
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil as a Carrier for Cancer Nanotherapeutics: A Comparative Study of Liposome, PLGA, and Magnetic Nanoparticles Delivery to Tumors.
Garanina AS; Vishnevskiy DA; Chernysheva AA; Valikhov MP; Malinovskaya JA; Lazareva PA; Semkina AS; Abakumov MA; Naumenko VA
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004431
[TBL] [Abstract][Full Text] [Related]
9. Rational Design of Nanotherapeutics Based on the Five Features Principle for Potent Elimination of Cancer Stem Cells.
Zhang Z; Deng Q; Xiao C; Li Z; Yang X
Acc Chem Res; 2022 Feb; 55(4):526-536. PubMed ID: 35077133
[TBL] [Abstract][Full Text] [Related]
10. Multistage nanoparticle delivery system for deep penetration into tumor tissue.
Wong C; Stylianopoulos T; Cui J; Martin J; Chauhan VP; Jiang W; Popovic Z; Jain RK; Bawendi MG; Fukumura D
Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2426-31. PubMed ID: 21245339
[TBL] [Abstract][Full Text] [Related]
11. Predictive modeling of in vivo response to gemcitabine in pancreatic cancer.
Lee JJ; Huang J; England CG; McNally LR; Frieboes HB
PLoS Comput Biol; 2013; 9(9):e1003231. PubMed ID: 24068909
[TBL] [Abstract][Full Text] [Related]
12. Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization.
Wu YW; Lee DY; Lu YL; Delila L; Nebie O; Barro L; Changou CA; Lu LS; Goubran H; Burnouf T
Platelets; 2023 Dec; 34(1):2237134. PubMed ID: 37580876
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery to solid tumors with heterogeneous microvascular networks: Novel insights from image-based numerical modeling.
Moradi Kashkooli F; Soltani M; Hamedi MH
Eur J Pharm Sci; 2020 Aug; 151():105399. PubMed ID: 32485347
[TBL] [Abstract][Full Text] [Related]
14. Imaging Nanotherapeutics in Inflamed Vasculature by Intravital Microscopy.
Wang Z
Theranostics; 2016; 6(13):2431-2438. PubMed ID: 27877245
[TBL] [Abstract][Full Text] [Related]
15. Towards Optimal Design of Cancer Nanomedicines: Multi-stage Nanoparticles for the Treatment of Solid Tumors.
Stylianopoulos T; Economides EA; Baish JW; Fukumura D; Jain RK
Ann Biomed Eng; 2015 Sep; 43(9):2291-300. PubMed ID: 25670323
[TBL] [Abstract][Full Text] [Related]
16. The Tumor Microenvironment as a Barrier to Cancer Nanotherapy.
Curtis LT; Frieboes HB
Adv Exp Med Biol; 2016; 936():165-190. PubMed ID: 27739048
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 tumors in nude mice.
Zhang B; Jin K; Jiang T; Wang L; Shen S; Luo Z; Tuo Y; Liu X; Hu Y; Pang Z
Sci Rep; 2017 Aug; 7(1):10071. PubMed ID: 28855534
[TBL] [Abstract][Full Text] [Related]
18. Polymeric micelles and nanoemulsions as tumor-targeted drug carriers: Insight through intravital imaging.
Rapoport N; Gupta R; Kim YS; O'Neill BE
J Control Release; 2015 May; 206():153-60. PubMed ID: 25776738
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of uptake and distribution of gold nanoparticles in solid tumors.
England CG; Gobin AM; Frieboes HB
Eur Phys J Plus; 2015 Nov; 130(11):. PubMed ID: 27014559
[TBL] [Abstract][Full Text] [Related]
20. A tumor cord model for doxorubicin delivery and dose optimization in solid tumors.
Eikenberry S
Theor Biol Med Model; 2009 Aug; 6():16. PubMed ID: 19664243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
